Uttam Reddy is a Nephrology physician affiliated with University of California, Irvine. OpenAlex indexes 50 publications with 902 citations (h-index 14).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
101 The City Dr S Bldg 30
Orange, CA 928683201
Telephone
714-456-7720Provider last certified this registry record 26 Mar 2025.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- SANOFI-AVENTIS U.S. LLCProgram year20252 payments
- Merck Sharp & Dohme LLCProgram year20251 payment
- SANOFI-AVENTIS U.S. LLCProgram year20242 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
37.5%Beta blocker9.9%Carvedilol53%Metoprolol Tartrate28%Metoprolol Succinate9%Labetalol Hcl7%Atenolol3%Part D<11 patientsCalcium channel blocker8%Nifedipine Er69%Amlodipine Besylate31%Part D≥81 patients+ 10 more classes in this area
Metabolism & gastrointestinal
33.2%Corticosteroid13.9%Prednisone100%Part D≥132 patientsProton pump inhibitor7.6%Pantoprazole Sodium83%Omeprazole17%Part D≥85 patients+ 8 more classes in this area
Hormonal (systemic)
6.6%Calcium-sensing Receptor Agonist5.2%Cinacalcet Hcl100%Part D≥49 patientsl-Thyroxine1.5%Levothyroxine Sodium100%Part D≥17 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Hybrid Telemedicine and In‐Person Care for Kidney Transplant Follow‐Up: A Qualitative Study
Clinical Transplantation
2025 - Stanford Integrated Psychosocial Assessment for Transplant as a Predictor for Kidney Transplant Rejection
American Journal of Transplantation
2025 - Outcomes After Preemptive Waitlisting for Kidney Transplantation in the United States
American Journal of Transplantation
2025 - Racial and Ethnic Disparities in Outcomes following Preemptive Kidney Transplant Waitlisting in the United States from 2009 to 2024
Journal of the American Society of Nephrology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Susan O’Brien, MD
University of California, Irvine
Steven Potkin, MD
University of California, Irvine
Mitchell Brin, MD
University of California, Irvine
Deborah Wing, MD
University of California, Irvine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”